These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10419904)

  • 1. STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells.
    de Groot RP; Raaijmakers JA; Lammers JW; Jove R; Koenderman L
    Blood; 1999 Aug; 94(3):1108-12. PubMed ID: 10419904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.
    de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L
    Mol Cell Biol Res Commun; 2000 May; 3(5):299-305. PubMed ID: 10964754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N; Frank DA; Griffin JD
    J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
    Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
    Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation.
    Nosaka T; Kitamura T
    Exp Hematol; 2002 Jul; 30(7):697-702. PubMed ID: 12135666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats.
    Frank DA; Varticovski L
    Leukemia; 1996 Nov; 10(11):1724-30. PubMed ID: 8892675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.
    Sexl V; Piekorz R; Moriggl R; Rohrer J; Brown MP; Bunting KD; Rothammer K; Roussel MF; Ihle JN
    Blood; 2000 Sep; 96(6):2277-83. PubMed ID: 10979977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcr/Abl activates transcription of the Bcl-X gene through STAT5.
    Gesbert F; Griffin JD
    Blood; 2000 Sep; 96(6):2269-76. PubMed ID: 10979976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
    Shuai K; Halpern J; ten Hoeve J; Rao X; Sawyers CL
    Oncogene; 1996 Jul; 13(2):247-54. PubMed ID: 8710363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity.
    Jacobberger JW; Sramkoski RM; Frisa PS; Ye PP; Gottlieb MA; Hedley DW; Shankey TV; Smith BL; Paniagua M; Goolsby CL
    Cytometry A; 2003 Aug; 54(2):75-88. PubMed ID: 12879454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
    Hoover RR; Gerlach MJ; Koh EY; Daley GQ
    Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells.
    Rhodes J; York RD; Tara D; Tajinda K; Druker BJ
    Exp Hematol; 2000 Mar; 28(3):305-10. PubMed ID: 10720695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
    Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressing a carboxyl-terminal truncated STAT5.
    Ahmed M; Dusanter-Fourt I; Dugray A; Dubrez L; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Solary E; Vainchenker W; Turhan AG
    Leuk Lymphoma; 2001 Jul; 42(3):445-55. PubMed ID: 11699409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members.
    Ilaria RL; Van Etten RA
    J Biol Chem; 1996 Dec; 271(49):31704-10. PubMed ID: 8940193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition.
    Donato NJ; Wu JY; Zhang L; Kantarjian H; Talpaz M
    Blood; 2001 May; 97(9):2846-53. PubMed ID: 11313280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
    Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
    Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
    J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change.
    Rahmani M; Reese E; Dai Y; Bauer C; Kramer LB; Huang M; Jove R; Dent P; Grant S
    Mol Pharmacol; 2005 Apr; 67(4):1166-76. PubMed ID: 15625278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.